These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3360268)

  • 1. Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites.
    Gentilini P; Laffi G; Meacci E; La Villa G; Cominelli F; Pinzani M; Buzzelli G
    Gastroenterology; 1988 Jun; 94(6):1470-7. PubMed ID: 3360268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
    Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
    Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
    Morimoto K; Ikata T; Tounai T
    Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrarenal thromboxane A2 generation reduces the furosemide-induced sodium and water diuresis in cirrhosis with ascites.
    Pinzani M; Laffi G; Meacci E; La Villa G; Cominelli F; Gentilini P
    Gastroenterology; 1988 Oct; 95(4):1081-7. PubMed ID: 3165896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effects of the inhibitor of thromboxane A2-synthetase OKY-046.
    Hatziantoniou C; Papanikolaou N
    Experientia; 1986 Jun; 42(6):613-5. PubMed ID: 3522267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites.
    Laffi G; Marra F; Carloni V; Azzena G; De Feo ML; Pinzani M; Tosti-Guerra C; Gentilini P
    Gastroenterology; 1992 Sep; 103(3):1017-21. PubMed ID: 1386823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of prostaglandins and renal function after hepatic resection.
    Matsumata T; Yamamoto K; Shirabe K; Shimada M; Sugimachi K; Takesue F; Muto Y; Ikeda T
    Hepatogastroenterology; 1997; 44(15):774-8. PubMed ID: 9222688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the thromboxane A2 synthesis inhibitor OKY-046 on renal function in rabbits following release of unilateral ureteral obstruction.
    Loo MH; Egan D; Vaughan ED; Marion D; Felsen D; Weisman S
    J Urol; 1987 Mar; 137(3):571-6. PubMed ID: 3820396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of OKY-046, a selective thromboxane synthetase inhibitor, on blood pressure and thromboxane synthesis in spontaneously hypertensive rats.
    Gomi T; Ikeda T; Ishimitsu T; Uehara Y
    Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):139-44. PubMed ID: 2608692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of vessel wall prostacyclin by selective thromboxane synthetase inhibitor OKY 1581.
    Mehta J; Mehta P; Ostrowski N
    Prostaglandins Leukot Med; 1983 Sep; 12(1):49-52. PubMed ID: 6356153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a selective thromboxane synthetase inhibitor (OKY-046) in patients with coronary artery disease during exercise.
    Shikano M; Ito T; Ogawa K; Satake T
    Jpn Heart J; 1987 Sep; 28(5):663-74. PubMed ID: 3323562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of thromboxane A2 in the hypotensive effect of captopril in essential hypertension.
    Kudo K; Abe K; Chiba S; Sato M; Yasujima M; Kohzuki M; Omata K; Tanno M; Tsunoda K; Yoshinaga K
    Hypertension; 1988 Feb; 11(2):147-52. PubMed ID: 3277911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of thromboxane A2 (TxA2) in allergic cutaneous reactions and the effect of (E)-3-[p-(1H-imidazol-1-ylmethyl) phenyl]-2-propenoic acid hydrochloride (OKY-046), a TxA2 synthetase inhibitor.
    Nagai H; Yakuo I; Nakatomi I; Inagaki N; Koda A
    Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(3):125-30. PubMed ID: 2710796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit nephrotoxic nephritis: effect of a thromboxane synthetase inhibitor on evolution and prostaglandin excretion.
    Shinkai Y; Cameron JS
    Nephron; 1987; 47(3):211-9. PubMed ID: 3317092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of thromboxane synthase inhibitors on renal function.
    Jackson EK; Goto F; Uderman HD; Workman RJ; Herzer WA; FitzGerald GA; Branch RA
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):183-90. PubMed ID: 3285227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the thromboxane A2 synthetase inhibitor OKY-046 in a warm ischemia-reperfusion rat model.
    Garvin PJ; Niehoff ML; Robinson SM; Heisler T; Salinas-Madrigal L; Contis J; Solomon H
    Transplantation; 1996 May; 61(10):1429-34. PubMed ID: 8633364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effects of OKY-046.HCl, a selective thromboxane (TX) A2 synthetase inhibitor, on platelet activating factor (PAF)-induced airway hyperresponsiveness in guinea pigs].
    Takehana Y; Hamano S; Kikuchi S; Kusama H; Komatsu H; Okegawa T; Ikeda S
    Nihon Yakurigaku Zasshi; 1990 Jan; 95(1):21-30. PubMed ID: 2303203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.